Estler, Bent; Rudolph, Volker; Seleznova, Yana; Shukri, Arim - In: The European Journal of Health Economics 24 (2022) 3, pp. 349-358
Aim: To evaluate the cost-effectiveness of the MitraClip device (MitraClip) in addition to optimal medical therapy (OMT …-to-severe or severe secondary mitral regurgitation receiving MitraClip plus OMT compared with OMT alone from the statutory health … MitraClip strategy was cost-effective with a probability of 80% at a willingness-to-pay threshold of € 67,000/QALY. Conclusions …
